October 16, 2026
The LightScalpel CO2 Surgical Laser systems are FDA-cleared and intended for use in laser neurosurgery procedures for incision, excision, ablation, and/or vaporization of soft tissue for treatment of:
- Posterior fossa tumors
- Peripheral neurectomy
- Benign and malignant tumors and cysts
- including gliomas, meningiomas (including basal tumors), acoustic neuromas, lipomas, and large tumors
- Arteriovenous malformation
- Pituitary gland tumors (transphenoidal approach)

